Sharekhan

BUY NOW Buy Vivanza Biosciences Ltd Stock

Open Free Demat and Trading account in 15 minutes

Overview
Market Data
Market Depth
Option Chain
News
Fundamental
Shareholding Pattern
Corporate Action
Peers
Company Info
FAQ’s

Home Stock Vivanza Biosciences Ltd

Fri 12/06/2026,13:16:0

NSE

BSE

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1.70

Previous Close

₹ 1.70

Volume

8599

Mkt Cap ( Rs. Cr)

₹6.80

High

₹ 1.70

Low

₹ 1.70

52 Week High

₹ 2.72

52 Week Low

₹ 1.52

Book Value Per Share

₹ 1.09

Dividend Yield

0.00

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Vivanza Biosciences Ltd

Your Vote -

Buy

50.00%

Hold

25.00%

Sell

25.00%

50.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Vivanza Biosciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

Vivanza Biosciences posts Q4 net loss of Rs 0.27 cr

8 May 2026, 9:40AM The company reported standalone net loss during the quarter stood at Rs 0.27 crore as compared to net loss of Rs 0.97 crore in the previous year quart
Vivanza Biosciences - Non Applicability Of Related Party Transaction Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015

7 May 2026, 11:17PM This is to inform you that as per Regulation 15(2) of SEBI (LODR) Regulations, 2015, Corporate Governance and the above mentioned provisions such as R
Vivanza Biosciences - Results- Quarterly And Year To End Dated 31St March 2026

7 May 2026, 11:09PM Audited Standalone Financial Results for the Quarter and Year ended on 31st March, 2026, Took note of resignation of Hemant A. Parikh as an MD and Cha
Vivanza Biosciences - Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended On 31St March, 2026

7 May 2026, 10:58PM Consideration of Audited Financial Results Standalone and Consolidated as per Indian Accounting Standards (Ind AS) along with the Audit Report of the
Vivanza Biosciences - Board Meeting Intimation for Rescheduling Of Board Meeting-Intimation Under Regulation 29 Of SEBI (List

4 May 2026, 3:10PM Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 ,inter alia, to consider
Vivanza Biosciences - Announcement under Regulation 30 (LODR)-Change in Management

30 Apr 2026, 4:10PM Intimation Regarding Resignation of Company Secretary & Compliance Officer pursuant to Regulation 30 of SEBI(LODR) Regulations, 2015.
Vivanza Biosciences - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

30 Apr 2026, 4:05PM Intimation regarding Resignation of Company Secretary & Compliance Officer pursuant to Regulation 30 of SEBI(LODR) Regulations, 2015.
Vivanza Biosciences - Board Meeting Intimation for Board Meeting Intimation For Intimation Under Regulation 29(1)(A) And Regu

28 Apr 2026, 2:25PM Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2026 ,inter alia, to consider
Vivanza Biosciences - Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligatio

14 Apr 2026, 4:18PM Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015, attaching herewith Non-Applicability of Statement of Deviation.
Vivanza Biosciences has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

14 Apr 2026, 1:51PM As of March 2026, 20.02% is owned by Indian Promoters and 79.98% by Public. <p align=justify> Top two Promoters holding highest number of shares of Vi
Vivanza Biosciences - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

9 Apr 2026, 12:39PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
Vivanza Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

7 Apr 2026, 1:57PM Enclosed herewith Compliance Certificate under Regulation 74(5) of SEBI(DP) Regulations, 2018 for the March Quarter and Year Ended 31st March, 2026.
Vivanza Biosciences - Announcement under Regulation 30 (LODR)-Change in Directorate

17 Mar 2026, 3:29PM Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding intimation of Resignation of Mr. Hemant Amrish Parikh as Non-Executive Direc
Vivanza Biosciences - Announcement under Regulation 30 (LODR)-Resignation of Director

17 Mar 2026, 2:42PM Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 We wish to inform you that Mr. Hemant Amrish Pari

Key fundamentals

Evaluate the intrinsic value of Vivanza Biosciences Ltd stock

Name	March-26	March-25	March-24	March-23	March-22
Assets	11.8944	10.113	7.9781	10.9623	5.5128
Liabilities	11.8944	10.113	7.9781	10.9623	5.5128
Equity	4	4	4	4	4
Gross Profit	0.7092	-0.3634	0.7998	0.7212	0.049
Net Profit	0.3749	-0.6951	0.3174	0.5691	0.4636
Cash From Operating Activities	-1.2136	-2.4688	1.7835	0.1607	-0.6771
NPM(%)	0.33	-23.62	2.2	4	5.06
Revenue	112.231	2.9428	14.4132	14.2071	9.1475
Expenses	111.5218	3.3062	13.6134	13.4859	9.0984
ROE(%)	8.6	-15.94	7.28	13.05	10.63

Shareholding Pattern

Corporate Action

XD-Date	Dividend-Amount	Dividend-%	Dividend Yield(%GE)	Price on that day

From Year	To Year	Class of Share	Authorized Capital(Crores)	Issued Capital(Crores)	Paid Up Shares(NOS)	Paid Up Face Value	Paid Up Capital(Crores)
2024	2025	Equity Share	4.00	4.00	40000000.00	1	4.00
2023	2024	Equity Share	4.00	4.00	40000000.00	1	4.00
2022	2023	Equity Share	4.00	4.00	40000000.00	1	4.00
2021	2022	Equity Share	4.00	4.00	4000000.00	10	4.00
2020	2021	Equity Share	4.00	4.00	4000000.00	10	4.00
2019	2020	Equity Share	4.00	4.00	4000000.00	10	4.00
2018	2019	Equity Share	4.00	4.00	4000000.00	10	4.00
2017	2018	Equity Share	4.00	4.00	4000000.00	10	4.00
2016	2017	Equity Share	4.00	4.00	4000000.00	10	4.00
2015	2016	Equity Share	4.00	0.19	188000.00	10	0.19
2014	2015	Equity Share	4.00	3.76	3760000.00	10	3.76
2013	2014	Equity Share	4.00	3.76	3760000.00	10	3.76
2012	2013	Equity Share	4.00	3.76	3760000.00	10	3.76
2011	2012	Equity Share	4.00	3.76	3760000.00	10	3.76
2010	2011	Equity Share	4.00	3.76	3760000.00	10	3.76
2009	2010	Equity Share	4.00	3.76	3760000.00	10	3.76
2001	2002	Equity Share	4.00	3.76	3760000.00	10	3.76
1999	2000	Equity Share	4.00	3.76	3760000.00	10	3.76
1996	1999	Equity Share	4.00	3.76	3760000.00	10	3.76
1995	1996	Equity Share	4.00	3.76	3760000.00	10	3.76

Announcement Date	Price	Bonus Ratio	Record Date

Fund	Market Value(CR)	% Hold
No Records Found

Peers

Other companies within the same industry or sector that are comparable to Vivanza Biosciences Ltd

Company	Price	Price (% change)	pe(x)	EV/EBITDA(x)	ROE(%)	ROCE(%)
Albert David Ltd	725.90	4.18	0.00	0.97	-26.19	0.69
Lotus Eye Hospital and Institute Ltd	136.95	2.13	4550.00	3.54	0.39	0.00
Bharat Immunological and Biologicals Corporation Ltd	17.00	1.07	0.00	7.34	-39.50	0.00
Astec Lifesciences Ltd	777.00	0.84	0.00	3.33	-363.14	0.00

Company Info

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Read More

Parent Organisation

Vivanza Biosciences Ltd.

Founded

06/03/1982

Managing Director

Mr.J A Mehta

NSE Symbol

FAQ

The current price of Vivanza Biosciences Ltd is ₹ 1.70.

The 52-week high for Vivanza Biosciences Ltd is

The market capitalization of Vivanza Biosciences Ltd is currently ₹ 6.80. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Vivanza Biosciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Vivanza Biosciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vivanza Biosciences Ltd shares.

The CEO of Vivanza Biosciences Ltd is Mr.J A Mehta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT